School of Business Administration
Philadelphia, PA 19144
NBER Working Papers and Publications
|November 2013||Effects of Physician-Directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence|
with Dhaval M. Dave: w19592
Spending on prescription drugs (Rx) represents one of the fastest growing components of U.S. healthcare spending, and has coincided with an expansion of pharmaceutical promotional spending. Most (83%) of Rx promotion is directed at physicians in the form of visits by pharmaceutical representatives (known as detailing) and drug samples provided to physicians' offices. Such promotion has come under increased public scrutiny, with critics contending that physician-directed promotion may play a role in raising healthcare costs and may unduly affect physicians' prescribing habits towards more expensive, and possibly less cost-effective, drugs. In this study, we bring longitudinal evidence to bear upon the question of how detailing impacts physicians' prescribing behaviors. Specifically, we ...
Published: Anusua Datta & Dhaval Dave, 2016. "Effects of Physician-directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence," Health Economics, , pages n/a-n/a. citation courtesy of